SUN PHARMA ADVANCED RESEARCH COMPANY
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Income Statement History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹239 Cr | ₹137 Cr | ₹253 Cr | ₹77 Cr | ₹183 Cr |
Sales | - | - | - | - | - |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹239 Cr | ₹137 Cr | ₹253 Cr | ₹77 Cr | ₹183 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹239 Cr | ₹137 Cr | ₹253 Cr | ₹77 Cr | ₹183 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | - | - | - | - | - |
Raw Material Consumed | - | - | - | - | - |
Opening Raw Materials | - | - | - | - | - |
Purchases Raw Materials | - | - | - | - | - |
Closing Raw Materials | - | - | - | - | - |
Other Direct Purchases / Brought in cost | - | - | - | - | - |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹5.75 Cr | ₹4.62 Cr | ₹4.60 Cr | ₹5.14 Cr | ₹5.08 Cr |
Electricity & Power | ₹5.75 Cr | ₹4.62 Cr | ₹4.60 Cr | ₹5.14 Cr | ₹5.08 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹107 Cr | ₹98 Cr | ₹92 Cr | ₹93 Cr | ₹81 Cr |
Salaries, Wages & Bonus | ₹98 Cr | ₹89 Cr | ₹83 Cr | ₹82 Cr | ₹70 Cr |
Contributions to EPF & Pension Funds | ₹4.36 Cr | ₹4.04 Cr | ₹3.80 Cr | ₹5.48 Cr | ₹5.22 Cr |
Workmen and Staff Welfare Expenses | ₹3.11 Cr | ₹3.12 Cr | ₹2.20 Cr | ₹6.07 Cr | ₹5.77 Cr |
Other Employees Cost | ₹1.97 Cr | ₹1.87 Cr | ₹2.11 Cr | - | - |
Other Manufacturing Expenses | ₹180 Cr | ₹134 Cr | ₹210 Cr | ₹30 Cr | ₹18 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹3.57 Cr | ₹3.20 Cr | ₹3.12 Cr | ₹2.58 Cr | ₹2.49 Cr |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹177 Cr | ₹131 Cr | ₹207 Cr | ₹28 Cr | ₹15 Cr |
General and Administration Expenses | ₹154 Cr | ₹84 Cr | ₹78 Cr | ₹251 Cr | ₹221 Cr |
Rent , Rates & Taxes | ₹0.14 Cr | ₹0.17 Cr | ₹0.16 Cr | ₹0.16 Cr | ₹2.11 Cr |
Insurance | ₹0.76 Cr | ₹1.51 Cr | ₹1.43 Cr | ₹1.21 Cr | ₹1.22 Cr |
Printing and stationery | ₹8.63 Cr | ₹4.34 Cr | ₹5.25 Cr | ₹5.05 Cr | ₹3.27 Cr |
Professional and legal fees | ₹134 Cr | ₹71 Cr | ₹64 Cr | ₹236 Cr | ₹203 Cr |
Traveling and conveyance | ₹3.88 Cr | ₹1.00 Cr | ₹1.88 Cr | ₹4.46 Cr | ₹5.67 Cr |
Other Administration | ₹11 Cr | ₹6.88 Cr | ₹7.89 Cr | ₹9.31 Cr | ₹11 Cr |
Selling and Distribution Expenses | - | - | - | - | - |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹5.68 Cr | ₹2.41 Cr | ₹3.48 Cr | ₹6.81 Cr | ₹8.80 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | ₹0.11 Cr | - | - | - | ₹2.10 Cr |
Losson foreign exchange fluctuations | ₹2.07 Cr | ₹0.84 Cr | - | ₹4.54 Cr | ₹4.63 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹3.50 Cr | ₹1.57 Cr | ₹3.48 Cr | ₹2.27 Cr | ₹2.07 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹453 Cr | ₹324 Cr | ₹388 Cr | ₹387 Cr | ₹334 Cr |
Operating Profit (Excl OI) | ₹-214 Cr | ₹-187 Cr | ₹-135 Cr | ₹-310 Cr | ₹-151 Cr |
Other Income | ₹11 Cr | ₹6.85 Cr | ₹5.41 Cr | ₹9.76 Cr | ₹14 Cr |
Interest Received | ₹7.60 Cr | ₹1.41 Cr | ₹0.90 Cr | ₹2.93 Cr | ₹3.14 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | ₹4.89 Cr | ₹0.26 Cr | ₹0.13 Cr | - |
Profits on sale of Investments | - | - | - | - | ₹5.18 Cr |
Provision Written Back | - | - | ₹0.20 Cr | - | - |
Foreign Exchange Gains | - | - | ₹3.01 Cr | - | - |
Others | ₹3.28 Cr | ₹0.54 Cr | ₹1.04 Cr | ₹6.70 Cr | ₹5.19 Cr |
Operating Profit | ₹-203 Cr | ₹-180 Cr | ₹-130 Cr | ₹-300 Cr | ₹-138 Cr |
Interest | ₹7.64 Cr | ₹13 Cr | ₹11 Cr | ₹2.68 Cr | ₹0.09 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹7.15 Cr | ₹13 Cr | ₹10 Cr | ₹1.94 Cr | ₹0.09 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹0.49 Cr | ₹0.47 Cr | ₹0.61 Cr | ₹0.73 Cr | - |
PBDT | ₹-211 Cr | ₹-193 Cr | ₹-140 Cr | ₹-303 Cr | ₹-138 Cr |
Depreciation | ₹12 Cr | ₹10 Cr | ₹11 Cr | ₹9.48 Cr | ₹7.55 Cr |
Profit Before Taxation & Exceptional Items | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr | ₹-145 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr | ₹-145 Cr |
Provision for Tax | - | - | - | - | - |
Current Income Tax | - | - | - | - | - |
Deferred Tax | - | - | - | - | - |
Other taxes | - | - | - | - | - |
Profit After Tax | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr | ₹-145 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr | ₹-145 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹-1,371 Cr | ₹-1,169 Cr | ₹-1,019 Cr | ₹-704 Cr | ₹-541 Cr |
Appropriations | ₹-1,593 Cr | ₹-1,372 Cr | ₹-1,170 Cr | ₹-1,017 Cr | ₹-686 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹-1.35 Cr | ₹-1.70 Cr | ₹-1.53 Cr | ₹2.47 Cr | ₹18 Cr |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹-6.86 | ₹-7.48 | ₹-5.77 | ₹-11.92 | ₹-5.55 |
Adjusted EPS | ₹-6.86 | ₹-7.48 | ₹-5.77 | ₹-11.92 | ₹-5.55 |
Compare Income Statement of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,320.7 Cr | -12.6% | -40.3% | 22.5% | Stock Analytics | |
SYNGENE INTERNATIONAL | ₹27,320.2 Cr | -2.8% | -4.1% | 1.5% | Stock Analytics | |
LATENT VIEW ANALYTICS | ₹10,210.8 Cr | -0.4% | -5.1% | 38.7% | Stock Analytics | |
JUST DIAL | ₹9,403.3 Cr | 3.8% | 32.4% | 64.9% | Stock Analytics | |
DREAMFOLKS SERVICES | ₹2,804.5 Cr | -4.2% | 6.4% | 24.9% | Stock Analytics | |
EKI ENERGY SERVICES | ₹949.7 Cr | -0.9% | 4.1% | -24% | Stock Analytics |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMA ADVANCED RESEARCH COMPANY | -12.6% |
-40.3% |
22.5% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses